✦ LIBER ✦

Carboplatin (C) and Gemcitabine (G) in advanced non small cell lung cancer (NSCLC): An effective and well tolerated regimen

✍ Scribed by Domine, M; Casado, V; Estevez, L.G; Leon, A; Martin, J.I; Castillo, M; Robles, L; Lobo, F

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

29 P - Gemcitabine: an active well toler

✍ F. de Braud; E. Munzone; F. Nole; T. De Pas; M.S. Aapro 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Gemcitabine + ALIMTA™ in advanced non-sm

✍ Ettinger, D.S; Bunn, P.A; Le Chevalier, T; Kelly, K; Monnerat, C 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Ifosfamide and gemcitabine in advanced n

✍ Gatzemeier, O.; Manegold, C.; Eberhard, W.; Wilke, H.; Chomy, F.; Chomy, P.; Kha 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Past, present, and future of gemcitabine

✍ Edelman, Martin J 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Gemcitabine and cisplatin for advanced n

✍ Casal, J.; Grande, C.; Caeiro, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Carboplatin/vinorelbine is active and we

✍ Horvath, L.; Boyer, M.; Clarke, S.; Beale, P.; Beith, J.; Cox, K.; Underhill, C. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 165 KB